MTAP Deficiency as a Metabolic Vulnerability in Cancer: Implications for Synthetic Lethal Therapy. [PDF]
Ikushima H, Kage H.
europepmc +1 more source
Identification of METTL3 and PRMT5 as an oncogenic pair for the prognosis and therapeutic targets of colorectal cancer subtype. [PDF]
Zhao Q +9 more
europepmc +1 more source
PRMT5-mediated intron retention triggers innate and adaptive immunity against cancer. [PDF]
Blaszczak W +10 more
europepmc +1 more source
Inhibition of PRMT5 reduces angiogenesis in a corneal neovascularization model by blocking NLRP3-mediated pyroptosis. [PDF]
Mao J +8 more
europepmc +1 more source
Exploring the BICC1 Interactome in HEK293T Cells: Insights Into RNA-Mediated Protein Networks and Biomolecular Condensates. [PDF]
do Amaral-Prado HM +7 more
europepmc +1 more source
Structure-Guided Discovery of Novel Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitors. [PDF]
Huang C +4 more
europepmc +1 more source
Affinity purification contaminants identified by cryo-EM and mass spectrometry. [PDF]
Belcher ER +3 more
europepmc +1 more source
The detection of MTAP loss in non-small cell lung cancer: a novel biomarker with therapeutic implications. [PDF]
Choi E, Koorapati G, Kumar PA.
europepmc +1 more source
Quantitative Global Proteomics of Formalin-Fixed Paraffin-Embedded Tumors Identifies Dimethylated G3BP1 at Arginine 460 as a Robust Pharmacodynamic Biomarker of Methylthioadenosine Phosphorylase-Selective Protein Arginine Methyltransferase 5 Inhibition. [PDF]
Tu A +10 more
europepmc +1 more source
PCK2-Mediated PQBP1 Lactylation Promotes Asthmatic Inflammation through PRMT5 Inhibition. [PDF]
Bai Q +10 more
europepmc +1 more source

